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Cocaine abuse during pregnancy has been associated with numerous adverse perinatal outcomes. Aims: The 
present study was to determine whether prenatal cocaine exposure induced apoptosis and the possible role of 
Bcl-2 family genes in the programming cell death in fetal rat brain. Main methods: Pregnant rats were treated 
with cocaine subcutaneously (30 & 60 mg/kg/day) from day 15 to 21 of gestation. Then the fetal and maternal 
brains were isolated. Key findings: Cocaine produced a dose-dependent decrease in fetal brain weight and 
brain/body weight ratio (P<0.05). Apoptotic nuclei in fetal brain were increased from 2.6 ± 0.1 (control) to 8.1± 0.6 
(low dose) and 10.4 ± 0.2% (high dose) (P<0.05). In accordance, cocaine dose dependently increased activities of 
caspase-3, caspase-8, and caspase-9 (% of control) in the fetal brain by 177%, 155%, 174%, respectively, at 30 
mg/kg/day, and by 191%, 176%, 274%, respectively, at 60 mg/kg/day. In contrast, cocaine showed no effect on 
caspase activities in the maternal brain. Cocaine produced a dose-dependent increase in both Bcl-2 and Bax pro-
tein expression in the fetal brain, and increased the ratio of Bax/Bcl-2 at dose of 30 mg/kg/day (P<0.05). Sig-
nificance: Our study has demonstrated that prenatal cocaine exposure induces apoptosis in the fetal brain, and 
suggested that up-regulating Bax/Bcl-2 gene expression may be involved in cocaine-induced apoptosis. The in-
creased apoptosis of neuronal cells in the fetal brain is likely to play a key role in cocaine-induced neuronal de-
fects during fetal development. 
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Introduction 
Cocaine abuse among women of childbearing age 
is prevalent in the United States. It has been estimated 
that each year more than 100,000 infants who were 
exposed prenatally to cocaine are born in this country. 
Cocaine abuse during pregnancy has been associated 
with numerous adverse perinatal outcomes [1-5]. Al-
though teratogenic effects of cocaine on the human 
fetal brain, such as destructive lesions and distur-
bances of the neurodevelopmental program are well 
documented [3, 6], the underlying mechanisms remain 
controversial. Several previous studies have reported 
that cocaine induces apoptosis in fetal cardiomyocytes 
[7-9], endothelium [10-12], thymocytes [13], hepato-
cytes [14], and testes [15]. Compelling evidence has 
accumulated indicating that programmed cell death 
(apoptosis) plays an important role in neuronal devel-
opment [16-18] as well as in several brain diseases in-
cluding stroke, Alzheimer, Parkinson, and Huntington 
diseases [19-21]. A previous study demonstrated that 
cocaine induced apoptosis in cultured cortical neu-
ronal cells of fetal mice [22]. Most recent studies have 
further suggested that maternal cocaine exposed may 
increase cell death in the fetal nervous system [23-25]. 
Nivikova et al.[24] has detected cocaine expo-
sure-induced changes in expression of some apop-
tosis-related genes in the fetal mouse cerebral wall by 
microarray analysis and demonstrated that maternal 
cocaine exposure could influence transcriptional ex-
pression levels of multiple apoptosis related genes in 
fetal cerebral wall. However, whether maternal co-
caine exposure causes a typical apoptotic cell mor-
phological and biochemical damage, and induces 
changes in translational expression levels of apop-
tosis-related genes in fetal brain in vivo is unknown. 
The present study was therefore designed to test 
the hypothesis that maternal administration of cocaine 
during pregnancy caused apoptotic cell death in fetal 
rat brain. To understand the possible mechanisms 
underlying cocaine-induced apoptosis in the devel-Int. J. Med. Sci. 2008, 5 
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oping brain, we measured the activities of caspase-3, 
caspase-8, and caspase-9 and examined the effects of 
cocaine on Bax and Bcl-2 protein expression in fetal rat 
brain. 
Material and Methods 
Materials 
Cocaine, Hoechst 33258, ethidium bromide and 
apoptotic DNA ladder kit were purchased from Sigma 
(St. Louis, MO). Bax antibody was from PharMingen 
(San Diego, CA). Bcl-2 antibody was from Santa Cruz 
Biotechnology (Santa Cruz, CA). Horseradish peroxi-
dase (HRP)-conjugated anti-mouse IgG was from 
Amersham Life Science (Clearbrook, IL). Proteinase K 
and DNase-free Rnase were purchased from Boe-
hringer Mannheim (Indianapolis, IN). Colorimetric 
assay kits for caspase-3, caspase-8, and caspase-9 were 
from R&D Systems (Minneapolis, MN). 
Experimental animals and cocaine administration 
Time-dated pregnant Sprague-Dawley rats were 
purchased from Charles River Laboratories (Portage, 
MI), and were housed individually in Plexiglas acrylic 
plastic cages (46 × 24 × 20 cm) in an AAALAC accred-
ited animal facility. Maternal cocaine administration 
was conducted as described previously [9]. Briefly, 
eighteen pregnant rats were randomly divided into 
three groups: 1) control, 2) cocaine 30 mg/kg/day, and 
3) cocaine 60 mg/kg/day. Cocaine HCl was dissolved 
in saline at 10 mg/ml and injected subcutaneously into 
the pregnant rats at ~10:00 A.M. once a day, starting at 
day 15 of gestation. Saline-injected pregnant rats 
served as controls. Food and water were provided as 
desired. Pregnant dams were sacrificed by cervical 
dislocation on day 21 of gestation, and the fetal and 
maternal brains were isolated. For tissue slide prepa-
ration, fetal rat brains were fixed in 10% buffered for-
malin and embedded in paraffin. For the other studies, 
fresh tissues were used.  
All procedures and protocols used in the present 
study were approved by the Institutional Animal Care 
and Use Committee of Loma Linda University and 
followed the guidelines put forward in the National 
Institutes of Health Guide for the Care and Use of 
Laboratory Animals. 
DNA fragmentation on agarose Gel 
The characteristic formation of oligonu-
cleosome-sized fragments of multiples of ~200 bp 
producing typical DNA ladders on agarose gels is the 
biochemical hallmark of apoptosis. DNA ladders in 
fetal rat brains were examined as previously described 
using the apoptotic DNA ladder kit from Sigma [8, 9]. 
DNA was extracted from the brain according to the 
instruction of the kit. DNA (20 μg) was electrophore-
sed at 70 volts in 1.8% agarose gel in TBE buffer con-
taining 1 μg/ml ethidium bromide, and photographed 
with ultraviolet illumination. A 100-bp DNA ladder 
molecular weight marker was added to each gel as a 
reference for analysis of internucleosomal DNA frag-
mentation. 
Quantitative analysis of apoptotic cells 
Fluorescent DNA-binding dyes (Hoechst 33258) 
were used to define nuclear chromatin morphology as 
a quantitative index of apoptosis as described previ-
ously [9, 26]. Whole fresh fetal brains were isolated 
from each litter of the experimental groups and im-
mediately fixed in 10% buffered formalin and embed-
ded in paraffin. Then the fetal brain was sectioned 
(4-μm thick) vertically at the middle of each hemi-
sphere, and six sections from each brain were analyzed 
for the presence of apoptotic nuclei. The tissue sections 
were deparaffinized with xylene and rehydrated with 
graded dilutions of ethanol in water. The tissue sec-
tions were then stained with Hoechst 33258 at 8 μg/ml 
for 10 min at dark room. The slides were rinsing in 
distill water 3x for 5 minutes each time, and mounted 
with mounting medium. The nuclear morphology was 
examined by fluorescence microscopy. Individual nu-
clei were visualized at ×400, and cells were scored as 
apoptotic if they exhibited unequivocal nuclear chro-
matin condensation and/or fragmentation. Sample 
identity was concealed during scoring. To quantify 
apoptosis, one section was used to count apoptotic 
cells from a specific brain region, and counts from each 
side were averaged together. Adjacent sections were 
examined to verify the location of specific brain re-
gions on a particular section, in order to obtain con-
sistency in counting. 1,000 nuclei from random micro-
scopic fields were analyzed and the percentage of 
apoptotic cells was calculated as the number of apop-
totic cells/number of total cells × 100%.  
Western blot analysis 
The fresh fetal brain was homogenized in an 
ice-cold lysis buffer (20 mM HEPES, pH 7.5, 10 mM 
KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 1 mM 
DTT, 1 mM PMSF, 2 μg/ml aprotinin, 10 μg/ml leu-
peptin), followed by centrifugation at 12,000 ×g for 15 
min at 4 °C. The supernatant was collected, and pro-
tein concentration was determined using a standard 
colorimetric assay (Bio-Rad). Total protein was used to 
determine Bax and Bcl-2 expression as described pre-
viously [9, 26]. Equal amount of proteins (50 μg) were 
loaded in each lane and separated in 10% SDS-PAGE, 
transferred to nitrocellulose membranes, and incu-
bated with monoclonal antibody against Bax (1:250) or Int. J. Med. Sci. 2008, 5 
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Bcl-2 (1:500) in TBS-T buffer containing 5% nonfat milk 
for 1 h at room temperature. Bax and Bcl-2 protein 
expressions were detected from the same membrane. 
After washing, the membranes were incubated for 1 h 
with horseradish peroxidase (HRP)-conjugated 
anti-mouse IgG1 (1:2000) at room temperature, and 
visualized using an enhanced chemiluminescence de-
tection system. Results were quantified using a scan-
ning densitometer (model 670, Bio-Rad).  
Caspase activity assay 
Activities of caspase-3, caspase-8 and caspase-9 
were determined using the corresponding caspase 
activity detection kits (R&D Systems) as described 
previously [9, 26]. The assay is based on spectopho-
tometric detection of the chromophore p-nitroanilide 
(pNA) after cleavage from the labeled substrates of 
DEVD-pNA (for caspase-3), IETD-pNA (for caspase-8), 
and LEHD-pNA (for caspase-9), respectively. The pNA 
light emission can be quantified using a spectropho-
tometer or a microtiter plate reader at 405-nm. Com-
parison of the absorbance of pNA from an apoptotic 
sample with control allows determination of the fold 
increase in caspase activity. We followed the assay 
procedure from the kits with some modification to 
determine the caspase activities in our samples. 
Briefly, fresh whole fetal brain and half of maternal 
forebrain from each litter of each experimental group 
were isolated and homogenized in a chilled cell lysis 
buffer, and then incubated on ice for 10 minutes and 
centrifuge for 1 minute in a microcentrifuge (10,000x 
g). The supernatant was transferred to a fresh tube and 
protein concentration was determined using a stan-
dard colorimetric assay (Bio-Rad). The protein con-
centration of each sample was adjusted to 200 μg per 
50 μL of cell lysate using chilled cell lysis buffer. Then 
added 50 μL of 2X Reaction Buffer and 5 μL substrates 
of DEVD-pNA (for caspase-3), IETD-pNA (for cas-
pase-8), and LEHD-pNA (for caspase-9), respectively. 
Samples were incubated at 37 °C for 4 h and the en-
zyme-catalyzed release of pNA was quantified at 405 
nm using a microtiter plate reader. The values of co-
caine treated samples were normalized to the un-
treated controls, allowing determination of the fold 
increase in caspase activity. 
Statistical analysis 
Data were presented as the mean ± SEM. In all 
cases, n refers to the number of dams in each treatment 
group. Statistical analyses were performed by one-way 
ANOVA followed by Newman-Keuls post-hoc test. 
Differences were considered significant when P < 0.05. 
Results 
Effects of maternal cocaine administration on fetal 
brain weight 
Previously, we reported that the cocaine treat-
ment reduced fetal body weight [9]. In this experiment, 
maternal cocaine exposure (30 mg/kg/day) signifi-
cantly decreased fetal brain weight (0.194 ± 0.002 g vs. 
0.178 ± 0.002 g, p < 0.05). Cocaine also significantly 
decreased the ratio of fetal brain/body weight (g/g) 
(0.0372 ± 0.0006 vs. 0.0352 ± 0.0005, p < 0.05). However, 
there were no significant differences in fetal brain 
weight and the ratio of brain/body weight (g/g) be-
tween cocaine 30 mg/kg/day and 60 mg /kg/day 
groups (Table 1).  
Table 1. Effects of maternal cocaine administration on fetal 
brain weights 
Group  Brain weight (g) Ratio of Brain/Body weight 
Control 0.194  ± 0.002  0.0372 ± 0.0006 
Cocaine 30mg/kg/d 0.178 ± 0.002*  0.0352 ± 0.0005* 
Cocaine 60mg/kg/d 0.180 ± 0.001*  0.0356 ± 0.0004* 
Values are means ± SEM 
*P < 0.05 vs. control 
 
Effects of cocaine on fetal brain apoptosis 
Assessment of nuclear chromatin morphology by 
Hoechst 33258 staining indicated that cocaine in-
creased condensed and segmented apoptotic nuclei in 
the fetal brain (Fig. 1, the upper panel). In accordance, 
cocaine induced formation of oligonucleosome-sized 
fragments of DNA as ladders of ∼200 bp on agarose 
gels, a hallmark of apoptosis (Fig. 2). Quantification of 
cocaine-induced apoptotic nuclei defined by the fluo-
rescent DNA-binding dye Hoechst 33258 indicated 
that cocaine produced a dose-dependent increase in 
apoptosis in the fetal brain (Fig. 1, the lower panel). 
Effects of cocaine on caspase activities 
The activation of caspase is a unique feature of 
apoptotic cell death. We determined cocaine-induced 
activation of the protease activities of caspase-3, cas-
pase-8, and caspase-9. As shown in Figure 3, cocaine 
(30, 60 mg/kg/day) produced a dose-dependent in-
crease (% of control) in caspase-3 (177.7 ± 12.9, 191.1 ± 
18.5; P < 0.05), caspase-8 (155.2 ± 12.4, 276.3 ± 15.1; P < 
0.05) and caspase-9 (174.3 ± 27.9, 274.3 ± 40.9; P < 0.05) 
activities in the fetal brain. In contrast, cocaine did not 
significantly affect caspase-3 (140.4 ± 20.0, 148.3 ± 20.4; 
P > 0.05), caspase-8 (139.9 ± 36.0, 149.3 ± 20.9; P > 0.05) 
and caspase-9 (127.5 ± 14.6; 145.9 ± 26.6, P > 0.05) ac-
tivities in the maternal brain. 
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Figure 1. Effect of maternal cocaine administration on 
apoptosis in fetal rat brain. Cocaine was administered subcu-
taneously to the pregnant rats for 7 days as described in Meth-
ods. Tissue sections of fetal rat brain were stained with 
DNA-binding fluorescence dye Hoechst 33258, and nuclear 
morphology was examined by fluorescence microscopy. The 
top panels show nuclear morphologic changes induced by co-
caine (30 mg/kg/day & 60 mg/kg/day). The images were ran-
domly chosen from the fetal brains in each group. The arrows 
show condensed and fragmented apoptotic nuclei. The bottom 
panel shows quantitative data obtained from five animals from 
different mothers of each group. Data are means ± SEM. 
a P < 
0.05 vs. control; 
b P < 0.05 vs. cocaine 30 mg/kg/day. 
 
Figure 2. Cocaine-induced 
nucleosomal DNA frag-
mentation on agarose gels 
in fetal rat brain. Cocaine 
was administered subcuta-
neously to the pregnant rats 
for 7 days as described in 
Methods. Cocaine-induced 
nucleosomal DNA fragmen-
tation in fetal brain was 
separated in 1.8% agarose 
gels. The apoptotic DNA 
ladders shown were in the 
brain treated with 30 
mg/kg/day (lane 3) and 60 
mg/kg/day (lane 4), but not in 
the control brain (lane 2). DNA markers, ∅X174 DNA frag-
ments cut by HaeIII as size marker are shown in lane 1. The 
same results were obtained from five additional separate ex-
periments.  
 
 
 
 
 
 
Figure 3. Effects of maternal cocaine administration on 
caspase activities in fetal rat brain. Cocaine was administered 
subcutaneously to the pregnant rats for 7 days as described in 
Methods. Caspase activities in fetal rat brain were determined 
using the caspase activity detection kits (see Methods). Data are 
expressed as % of control, and are means ± SEM for 5 to 6 
experiments. 
a P < 0.05 vs. control, 
b P < 0.05 vs. cocaine 30 
mg/kg/day. 
 
 
 
 
 
Effects of cocaine on Bax and Bcl-2 protein levels 
To determine whether cocaine leads to changes in 
Bcl-2 family protein levels in fetal brain, we examined 
the Bcl-2 and Bax protein expression. As shown in 
Figure 4, Bax protein was minimally detected in con-
trol fetal brain. However, it was dose-dependent in-
creased (% of control) in cocaine 30 mg/kg/day (227.1 
± 48.61, P < 0.05) and cocaine 60 mg/kg/day (330.7 ± 
31.6, P < 0.05). Bax was minimally present, whereas 
Bcl-2 was constitutively expressed in normal fetal rat 
brain. As shown in Figure 4, cocaine also significantly 
increased Bcl-2 protein levels at the dose of 30 
mg/kg/day (145.2 ± 8.16, P < 0.05) and 60 mg/kg/day 
(278.8 ± 87.65, P < 0.05). The Bax-to-Bcl-2 ratio in fetal 
rat brain was determined at each point by using value 
that was normalized to the control protein level within 
each group (Fig. 4, bottom panel). The Bax-to-Bcl-2 
ratio was significantly higher at the dose of cocaine 30 
mg/kg per day than the control group (P < 0.05), but 
no difference at the dose of cocaine 60 mg/kg per day.  Int. J. Med. Sci. 2008, 5 
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Figure 4. Effects of maternal cocaine administration on Bax 
and Bcl-2 protein expression in fetal rat brain. Cocaine was 
administered subcutaneously to the pregnant rats for 7 days as 
described in Methods. Immunoblot analysis of Bax and Bcl-2 
proteins was performed in fetal rat brain. The top panel shows 
the representative immunoblots obtained for Bcl-2 and Bax at 
the expected size of 26 kDa and 21 kDa, respectively, and shows 
an increase in Bcl-2 and Bax in the brains treated with cocaine. 
The middle panel shows quantitative data obtained from five 
separate experiments. The bottom panel shows the Bax-to-Bcl-2 
ratio in fetal rat brain. Data are expressed as % of control, and 
are means ± SEM. *P<0.05 vs. control. 
Discussion 
We previously showed that maternal cocaine 
administration resulted in a decrease in fetal rat body 
weight [9]. The present study demonstrated that the 
maternal cocaine treatment caused a significant de-
crease in fetal brain weight, as compared with the sa-
line control group. This finding is consistent with the 
previous report in pregnant C57BL/6 mice, in which 
maternal subcutaneous administration of cocaine from 
gestation days 12-18 produced significant decreases in 
fetal body and brain weight [27]. The pair-fed studies 
demonstrated that maternal undernutrition was not a 
likely mediator of the effects caused by cocaine [27, 28]. 
Moreover, our data indicate that cocaine decreases 
fetal brain/body weight ratio, suggesting that cocaine 
have higher affinity toxic effects on the fetal brain than 
the body. Dow-Edwards [29] reported that fetal brain 
had between 26-42% more concentration of cocaine 
than fetal plasma after 90 min following either 30 or 60 
mg/kg cocaine given via intragastric intubation to 
Wistar pregnant rats. It was also reported that cocaine 
affinity for brain tissue is similar in the fetus and dam 
after subcutaneous injection of cocaine, whereas the 
cocaine metabolite benzoylecgonine concentrations in 
fetal brain were greater than those observed in mater-
nal brain [30]. Therefore, fetal brain exposure to co-
caine is somewhat prolonged. Our current finding that 
cocaine had no effect on the activities of the caspases in 
the maternal brain but only in the fetal brain, further 
support the idea that these high levels of cocaine or its 
active cocaine metabolite may contribute to the pro-
duction of neuronal apoptotic alterations in co-
caine-exposed offspring. Nassogne et al [6] reported 
that cocaine selectively affected embryonic neuronal 
cells, causing first a dramatic reduction of both num-
ber and length of neurites and then extensive neuronal 
death in co-cultures of neurons and glial cell from 
mouse embryonic brain. Taken all together, our study 
with previous reports demonstrated that cocaine ex-
posure in utero causes severe alterations in the fetal 
brain, they could account for the qualitative or quan-
titative defects in neuronal pathways that cause a ma-
jor handicap in brain function following in prenatal 
exposure to cocaine. 
 Although prenatal cocaine use during pregnancy 
appears detrimental to the fetus, a causal effect, 
mechanism of injury, and the pathway of cocaine in-
duced injury have not well been documented [4]. Pre-
vious studies have reported that cocaine does have 
indirect effect on the developing fetus. Cocaine in-
creases circulating catecholamine levels, which may 
induce uterine artery vasoconstriction and cause fetal 
chronic hypoxia, then, could result in altered fetal so-
matic and fetal brain development [31]. Our finding 
that cocaine decreased fetal body weight is consistent 
with our previous studies that chronic hypoxia caused 
fetal growth restriction [32]. Cocaine induced hypoxia 
and increased the susceptibility to hypoxia-induced 
brain damage as the outcomes associated with “crack 
baby syndrome” represents a common underlying 
mechanism [33]. On the other hand, cocaine can exert 
direct effects on both the fetal central and peripheral Int. J. Med. Sci. 2008, 5 
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nervous systems. Studies have demonstrated that 
prenatal cocaine exposure has direct long-term effects 
on brain structure and function [23-25, 31]. Our current 
finding of the asymmetric growth restriction with de-
creased fetal brain-to-body weight ratio further sug-
gests that direct cytotoxic effects of cocaine on the fetal 
brain are likely to exist. These data suggests that pre-
natal cocaine exposure has both indirect and direct 
effect on the developing fetal brain. 
Nassogne et al [22] demonstrated that cocaine 
induced injury by apoptosis in vitro cultured cortical 
neuronal cells of fetal mice. Whereas, our present 
study has demonstrated that cocaine induces apop-
tosis in the fetal brain when it was administrated to the 
mother in vivo. In the present study, cocaine-induced 
apoptosis in fetal brain was clearly demonstrated by 
morphological changes such as cell shrinkage and 
rounding, characteristic features of apoptotic death. 
Moreover, simultaneous assessment of nuclear chro-
matin morphology further verified that these cells 
eventually manifested typical apoptotic condensed 
and fragmented nuclei. Similar finding of co-
caine-induced apoptosis has been reported in mice 
hepatocytes [14]. In addition, we have confirmed that 
the process of apoptosis defined on the basis of cellular 
and nuclear chromatin morphology correlates with 
apoptosis defined on the basis of internucleosomal 
DNA fragmentation assessed by DNA gel electropho-
resis. The discrete ladder of DNA fragments demon-
strated by gel electrophoresis indicates the presence of 
DNA cleavage at linker regions producing dou-
ble-strand DNA fragments of integral multiples of 
about 200 bp in the cocaine-induced injury fetal brain. 
The demonstration of this nucleosomal ladder in the 
treatment brain strongly suggests that apoptotic DNA 
degradation with internucleosomal digestion by an 
endonuclease is involved in the cocaine-induced cell 
death in the brain. In present study, DNA was ex-
tracted from the whole fetal brain, so DNA fragmenta-
tion reflected the whole brain region. Future studies 
will be needed to study the specific brain region and 
cell type undergoing apoptosis in response to cocaine 
exposure. 
Apoptosis is a process of active cellular 
self-destruction that requires the expression of specific 
genes [34, 35]. Despite the diversity of signals that can 
induce cell death, these pathways share several fea-
tures in their execution. One mechanism, which is 
consistently implicated in apoptosis, reflects an or-
chestrated series of biochemical events that is carried 
out by a group of cytosolic proteases, termed caspases. 
The current finding that activities of caspase-8, cas-
pase-9 and caspase-3 were increased after prenatal 
cocaine exposure provides strong evidence that apop-
tosis is activated after cocaine exposure in fetus and 
may contribute to secondary cell injury and cell death. 
The increased activities of caspae-9 and caspase-3 in-
duced by cocaine suggests that cocaine-induced 
apoptosis in the fetal brain was likely mediated by 
mitochondria/cytochrome  c pathway [36]. On the 
other hands, cocaine-induced activation of caspase-8, 
which releases two active subunits, p18 and p10, into 
the cytosol, activates additional caspases that cleave 
other apoptosis-related substrates. Caspase-8 may be 
involved in death receptor-mediated apoptosis path-
way [37].   
Bcl-2 gene families are identified as apoptosis 
regulating genes. Off these genes, bax, bad, bak and 
bik promote cell death, whereas bcl-2 and bcl-XL in-
hibit apoptosis and promote cell survival [38, 39]. It 
has been shown that the Bcl-2 protein physically in-
teracts with several of its homologous proteins, in the 
form of heterotypic dimers. The most important inter-
actions are considered to lie in Bcl-2/Bax dimerization. 
Thus, we studied the temporal profile of bcl-2 and bax 
gene products in terms of protein expression in the 
fetal brain after cocaine exposure. The current findings 
that cocaine significantly increased the protein levels 
of Bcl-2 and Bax in fetal rat brain are consistent to pre-
vious reports that gene transcriptional levels of Bcl-2 
and Bax are up-regulated in fetal mouse cerebral wall 
[24]. The current result showed that bax gene expres-
sion was markedly induced and dose dependent in-
creased, suggesting that bax was upregulated and 
played an important role in the induction of apoptotic 
death in the fetal brain after cocaine exposure. How-
ever, in contrast to the aforementioned bcl-2 inhibiting 
apoptotic cell death, the present study in fetal rat brain 
found that bcl-2 expression was also increased in a 
dose dependent manner after cocaine exposure com-
pared to saline control. The increase in anti-apoptotic 
Bcl-2 protein in the fetal brain may serve as a com-
pensatory protection of the neural cells upon cocaine 
insult. Previous study [40] found that total Bcl-2 pro-
tein is increased in injured brain after traumatic brain 
injury. Neurons are resistant to ischemic injury when 
Bcl-2 protein is over-expressed in vivo [41-43]. 
Whether programmed cell death that occurs after brain 
injury is maladaptive or beneficial has been addressed 
in several studies in animal models of stroke, trauma, 
cerebral ischemia and excitotoxicity [44, 45]. These 
studies support the hypothesis that Bcl-2 protects 
neurons from injury. Thus, Bcl-2 expression could be 
an important factor that promotes survival of neurons 
injured after cocaine exposure. Although the expres-
sions of Bcl-2 and Bax, both of them, were increased, it 
was very interesting that the ratio of Bax/Bcl-2 (pro- to 
anti-apoptotic proteins) was also increased after co-Int. J. Med. Sci. 2008, 5 
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caine exposure in the current study. The findings 
support the notion that the relative concentrations of 
pro-apoptotic and anti-apoptotic genes may act as a 
rheostat for the cell death program [46]. 
In conclusion, our study has demonstrated that 
cocaine induces apoptosis in the fetal brain when it is 
administrated to the mother. As reported previously, 
our study also demonstrates fetal growth retardation 
after cocaine use. Moreover, our data indicate that co-
caine decreases fetal brain/body weight ratio. The 
finding of the increased caspases activities re-enforces 
the conclusion that cocaine induces apoptosis in the 
fetal brain. The current studies also suggest that mul-
tiple mechanisms may be involved in cocaine-induced 
apoptosis in the fetal brain. One of the apoptotic 
p a t h w a y s  i s  r e g u l a t e d  b y  s p e c i f i c  g e n e s .  O f  t h e s e  
genes, Bax is the key gene in upregulation of the co-
caine-induced apoptosis in the fetal brain. However, 
Bcl-2 expression could be an important factor that 
promotes survival of cocaine-injured neurons. These 
findings demonstrate that genes can be orchestrated in 
cocaine-induced apoptosis in fetal brain, and provide a 
rational for the further development of pharmacol-
ogical and molecular therapies targeting programmed 
cell death after cocaine use. 
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